These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
227 related articles for article (PubMed ID: 16463802)
21. [Current management of gout]. Miguel C; Mediavilla MJ Acta Med Port; 2011; 24(5):791-8. PubMed ID: 22525631 [TBL] [Abstract][Full Text] [Related]
22. [Treatment of hyperuricemia and gout]. Gröbner W; Walter-Sack I Med Monatsschr Pharm; 2005 May; 28(5):159-64; quiz 165-6. PubMed ID: 15912988 [No Abstract] [Full Text] [Related]
23. [HYPERURICEMIA AND POTENTIAL RISK OF CARDIOVASCULAR AND RENAL DISEASES]. Schils R; Krzesinski JM Rev Med Liege; 2016 May; 71(5):262-8. PubMed ID: 27337847 [TBL] [Abstract][Full Text] [Related]
24. [Febuxostat versus allopurinol for hyperuricemia]. Ziegler R Med Monatsschr Pharm; 2006 Oct; 29(10):384. PubMed ID: 17058902 [No Abstract] [Full Text] [Related]
25. Febuxostat (Uloric) for chronic treatment of gout. Med Lett Drugs Ther; 2009 May; 51(1312):37-8. PubMed ID: 19448587 [TBL] [Abstract][Full Text] [Related]
26. Case 3: acute gout-risk factors and inappropriate therapy. Weaver AL Am J Med; 2006 Nov; 119(11 Suppl 1):S9-12. PubMed ID: 17059914 [No Abstract] [Full Text] [Related]
27. Gout and hyperuricemia. Roubenoff R Rheum Dis Clin North Am; 1990 Aug; 16(3):539-50. PubMed ID: 2217957 [TBL] [Abstract][Full Text] [Related]
28. The problem of cardio-renal diseases in patients with gout. Ferri C Curr Med Res Opin; 2017 Nov; 33(sup3):9-13. PubMed ID: 28952391 [TBL] [Abstract][Full Text] [Related]
29. [Drug therapy for idiopathic hyperuricemia--introduction, dose, and side effects]. Yamanaka H Nihon Rinsho; 2003 Jan; 61 Suppl 1():202-8. PubMed ID: 12629718 [No Abstract] [Full Text] [Related]
30. Comment on: Gout: an independent risk factor for all-cause and cardiovascular mortality. Mascitelli L; Pezzetta F; Goldstein MR Rheumatology (Oxford); 2010 Jul; 49(7):1421-2; author reply 1422. PubMed ID: 20427295 [No Abstract] [Full Text] [Related]
31. Hyperuricemia and associated diseases. Becker MA; Jolly M Rheum Dis Clin North Am; 2006 May; 32(2):275-93, v-vi. PubMed ID: 16716880 [TBL] [Abstract][Full Text] [Related]
32. Asymptomatic hyperuricemia: perhaps not so benign? Neogi T J Rheumatol; 2008 May; 35(5):734-7. PubMed ID: 18464314 [No Abstract] [Full Text] [Related]
33. [Hyperuricemia]. Chizyński K; Rózycka M Pol Merkur Lekarski; 2005 Nov; 19(113):693-6. PubMed ID: 16498814 [TBL] [Abstract][Full Text] [Related]
34. Consider gout in patients with risk factors, regardless of age. Olaniyi-Leyimu BY Am Fam Physician; 2008 Jul; 78(2):176. PubMed ID: 18697500 [No Abstract] [Full Text] [Related]
35. [Allopurinol efficacy in patients with tophus gout and chronic renal failure]. Iakunina IA; Barskova VG; Nasonova VA Ter Arkh; 2006; 78(6):88-91. PubMed ID: 16881370 [No Abstract] [Full Text] [Related]
36. Hyperuricemia, gout, and cardiovascular disease: an update. Abeles AM Curr Rheumatol Rep; 2015 Mar; 17(3):13. PubMed ID: 25740704 [TBL] [Abstract][Full Text] [Related]
37. Serum uric acid and cardiovascular disease: recent developments, and where do they leave us? Baker JF; Krishnan E; Chen L; Schumacher HR Am J Med; 2005 Aug; 118(8):816-26. PubMed ID: 16084170 [TBL] [Abstract][Full Text] [Related]
38. Dose adjustment of allopurinol according to creatinine clearance does not provide adequate control of hyperuricemia in patients with gout. Dalbeth N; Kumar S; Stamp L; Gow P J Rheumatol; 2006 Aug; 33(8):1646-50. PubMed ID: 16783857 [TBL] [Abstract][Full Text] [Related]